Target intelligence / Profile preview

Metalloenzymes and metalloproteins requiring Zn²⁺ or Cu²⁺

Molecular classification
Enzyme, Metalloprotein, Oxidoreductase, Hydrolase
01

Overview

Metalloenzymes and metalloproteins requiring Zn²⁺ or Cu²⁺ represent a diverse and essential class of proteins that utilize metal ions as critical cofactors for biological activity. Zinc-dependent enzymes, such as carbonic anhydrases and matrix metalloproteinases (MMPs), are involved in a wide range of processes including pH regulation, tissue remodeling, and protein degradation (McCall et al., 2000, Journal of Nutrition). Copper-dependent proteins, including superoxide dismutase and cytochrome c oxidase, are vital for antioxidant defense and cellular energy production (Uauy et al., 1998, American Journal of Clinical Nutrition). These proteins are significant therapeutic targets; for instance, angiotensin-converting enzyme (ACE) is a primary target for treating hypertension, while MMPs are investigated in cancer and inflammatory diseases (Fingleton, 2008, Expert Opinion on Therapeutic Targets). Drugs targeting these molecules typically act by binding directly to the metal ion in the active site, thereby blocking substrate access or catalytic turnover (Patchett et al., 1980, Nature). However, the structural similarity of metal-binding sites across different enzyme families presents a major challenge for achieving drug selectivity and avoiding systemic toxicity (Vallee & Auld, 1990, Biochemistry).

Other names
Zinc-dependent enzymesCopper-dependent enzymesMetalloproteinsZn/Cu metalloenzymes
02

Mechanism of action

Inhibition of enzymatic activity through coordination with the metal ion in the active site or through the chelation of essential metal cofactors.

03

Biological functions

CatalysisRedox signalingStructural stabilizationProteolysisRespiration
04

Disease associations

CancerHypertensionNeurodegenerative diseaseWilson's diseaseMenkes diseaseInflammation
05

Safety considerations

Off-target inhibition of related metalloenzymesSystemic metal deficiencyPotential for metal-mediated toxicityPoor selectivity of hydroxamate-based inhibitors
06

Interacting drugs

Captopril

6 more in the full profile.

07

Biomarkers

Serum zinc levelsSerum copper levelsCeruloplasmin activityMatrix metalloproteinase expression

Beyond the preview

Go deeper on Metalloenzymes and metalloproteins requiring Zn²⁺ or Cu²⁺.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metalloenzymes and metalloproteins requiring Zn²⁺ or Cu²⁺.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call